Alimera, pSivida say FDA clears eye implant

September 26, 2014 9:41 PM

11 0

NEW YORK (AP) — Alimera Sciences and pSivida said Friday the FDA approved their eye disease implant Iluvien.

Iluvien is an implant delivered by injection that is intended to treat diabetic macular edema, a condition that can cause blurred vision and blindness. The implant is designed to gradually release tiny amounts of a corticosteroid medication for three years. Alimera Sciences plans to launch the drug ...

Also read: Israeli billionaire buys 15 percent stake in Atletico Madrid

Read more

To category page